KV Pharmaceutical Company
30 September 2013
US $100,000,000 First Lien Secured Term Loan FacilityLaw Debenture Trust Company of New York has been appointed as agent for K-V Pharmaceutical Company’s new $100 million credit facility. K-V emerged from Chapter 11 bankruptcy on September 16. This facility is a critical element of their $375 million recapitalization. K-V is specialty pharmaceutical company that focuses on women’s health care products.